dsip sbir Biz Opps: DoD 22.4 Annual BAA Topic Open DARPA HR0011SB20224-04, HR0011SB20224-05, HR0011SB20224-06 Capturing Non-dilutive Funding from Department

Deeper breathing becomes more comfortable

!

Some protocols involve longer continuous use for 6-12 months with ongoing monitoring

They are not intended to represent clinical evidence in humans, and 5-Amino-1MQ has not been approved by the FDA, EMA, or any other regulatory authority for any indication

BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations

Our COA requirement protects you